Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Biogen, Eisai's Alzheimer's drug succeeds in mid-stage trial, shares soar
(Reuters) - Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer’s drug showed positive results for patients who received the highe...
Alkermes Receives $50 Million Payment From Biogen Following Review of Preliminary Gastrointestinal Tolerability Data From the Ongoing BIIB098 Clinical Development Program
DUBLIN, June 6, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq.
This new diabetes drug can help reverse a fatal lung disorder
Pulmonary fibrosis can develop after lung injuries like infections, radiation or chemotherapy, or it can have an unknown cause, as in idiopathic pulmonary fibrosis, or IPF.
Ex-Millennium chief Deborah Dunsire looks for pipeline growth as Lundbeck's CEO
Neuroscience specialist Lundbeck has been running without a permanent CEO since last November when then-helmsman Kåre Schultz left for Teva’s top job.
U.S. judge tosses $140 million verdict against AbbVie in AndroGel case
(Reuters) - A U.
Europe recalls generic heart drug made in China on cancer fears
LONDON (Reuters) - A number of high blood pressure and heart drugs containing an ingredient made in China are being recalled across Europe after an impurity that may cause cancer was found in ...
Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection
PARIS, France I July 3, 2018 I ABIVAX (Euronext Paris.
Virus may boost immune system, study finds
July 3 (UPI) -- Researchers have discovered a virus may help an aging immune system, based on research involving mice.
Experimental drug stops Parkinson's disease progression in mice
Johns Hopkins researchers say they have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's disease itself—as well as its sympt...
China Focus: China develops smart vest to monitor heart and prevent disease
BEIJING, July 3 (Xinhua) -- Chinese researchers have developed high-tech clothing that can monitor heart rates in real time and offer early warnings about cardiovascular disease, Science and T...
Conatus Pharmaceuticals’ Pan-caspase Inhibitor Emricasan Improves Survival and Portal Hypertension in a Mouse Model of Cirrhosis
SAN DIEGO, CA, USA I July 02, 2018 I Conatus Pharmaceuticals Inc.
CVC Capital revs up rare disease ambitions with $3.5B Recordati buyout
Recordati has finally sealed a sale.
454
455
456
457
458
459
460
461
462
